Market research
2NH.F Naturhouse Health, S.A
F EUR Consumer Defensive
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 133M
- P/E ratio
- 14.8
- Analyst target
- Not available
- Dividend yield
- 13.%
- Beta
- 0.41
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- ISIN
- ES0105043006
- Market cap
- 133M
- P/E ratio
- 14.8
- Analyst target
- Not available
- Dividend yield
- 13.%
- Beta
- 0.41
About
About Naturhouse Health, S.A
Naturhouse Health, S.A. operates in the nutrition and dietetics industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and food and drinks, such as diet products for breakfast, snacks, and meal substitutes. It also offers cosmetics and body care products, including beauty products related to skincare during the slimming process comprising cellulite, firming products, etc.; and anti-ageing products. In addition, the company engages in the production, preparation, and marketing of dietary products; and marketing of medicinal herbs and natural cosmetics. It sells its products through directly operated stores and franchised Naturhouse centers. The company was formerly known as Housediet, S.L.U. and changed its name to Naturhouse Health, S.A. Naturhouse Health, S.A. was incorporated in 1991 and is based in Madrid, Spain. Naturhouse Health, S.A. is a subsidiary of Kiluva S.A.
Research context
Naturhouse Health, S.A appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 2NH.F discussion.
5 years, 6 months ago
Naturhouse Health, S.A is currently in a long term uptrend where the price is trading 4.6% above its 200 day moving average.
From a valuation standpoint, the stock is 98.3% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 1.9.
Naturhouse Health, S.A's total revenue sank by 29.2% to $12M since the same quarter in the previous year.
Its net income has increased by 23.9% to $2M since the same quarter in the previous year.
Based on the above factors, Naturhouse Health, S.A gets an overall score of 3/5.